Skip to main content

CTT Pharmaceuticals Holdings, Inc. Successfully Completes 2 Year PCAOB Audit

Written by Customer Service on . Posted in Public Companies.

TAMPA, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) — CTT Pharmaceuticals Holdings, Inc. (OTC: CTTH), is pleased to announce that the registered PCAOB Accounting Firm of DiPiazza, LaRocca, Heeter & Co., led by audit partner Matthew Stewart have successfully completed the 2 year audit of CTT Pharma. This comprehensive audit included the review of CTT’s bank statements, patents, contracts and share allocation over the past 2 years and has received the necessary approvals to allow CTT Pharma to be in compliance with PCAOB Regulations. The PCAOB Audit Letter and Audited Financials for 2022 and 2023 have been successfully uploaded to the OTC Markets Website for anyone to view. This important milestone will allow CTT to uplist at any point now and should also give existing shareholders, future shareholders, investment firms and potential partners including the U.S. Government and other partnerships that may arise the necessary confidence in our management team that on a day to day basis CTT is functioning at the highest level of integrity.

The Public Company Accounting Oversight Board protects investors and other stakeholders of public companies by ensuring that the auditor of a company’s financial statements has followed a set of strict guidelines to minimize audit risk. The PCAOB is a non-profit organization that regulates auditors of publicly traded companies and oversees the audits of public companies, brokers, and dealers registered with the U.S. Securities and Exchange Commission(SEC).

Ryan Khouri, CEO of CTT Pharma, stated, “This PCAOB Audit was very extensive and should ensure a level of confidence amongst existing and future shareholders, while allowing CTT the ability to uplist to the OTCQB.”

About CTT Pharmaceuticals Holdings, Inc.

CTT has granted and pending patents for our technology in the United States, Europe, Canada and several other countries around the world that allow for many drugs to be put on dissolvable strips and other oral products, including but not limited to Pharmaceuticals, Nicotine, Liraglutide, Vitamins, and Caffeine. This patented technology allows for better bioavailability/absorption, quick onset, and the ability to make low dose dissolvable strips.

CTT Pharma 813-606-0060

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.